{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:50:12Z","timestamp":1773291012626,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ijrobp.2011.05.033","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T13:09:45Z","timestamp":1318856985000},"page":"164-171","source":"Crossref","is-referenced-by-count":30,"title":["DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer"],"prefix":"10.1016","volume":"83","author":[{"given":"Brian M.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond H.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S.","family":"Roof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Fidias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.05.033_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib2","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/bjs.7175","article-title":"Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer","volume":"97","author":"Courrech Staal","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib4","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: Lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"Kennedy","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib6","first-page":"4368","article-title":"Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers","volume":"9","author":"Kishi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2007.10.026","article-title":"Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma","volume":"260","author":"Nam","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.20332","article-title":"Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma","volume":"92","author":"Uehara","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.03.031","article-title":"Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: Mature results of phase II study","volume":"60","author":"Choi","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2006.02.013","article-title":"Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer","volume":"65","author":"Roof","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib12","series-title":"AJCC cancer staging handbook: From the AJCC cancer staging manual\/American Joint Committee on Cancer","year":"2002"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/002215540405200314","article-title":"Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha","volume":"52","author":"Kerfoot","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib14","doi-asserted-by":"crossref","first-page":"37401","DOI":"10.1074\/jbc.C200418200","article-title":"Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export","volume":"277","author":"Meng","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib16","series-title":"Radiobiology for the radiologist","author":"Hall","year":"2006"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","article-title":"The Fanconi anaemia\/BRCA pathway","volume":"3","author":"D\u2019Andrea","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib18","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1158\/1078-0432.CCR-10-1027","article-title":"A marker of homologous recombination predicts pathological complete response to neoadjuvant chemotherapy in primary breast cancer","volume":"16","author":"Graeser","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib19","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1158\/1078-0432.CCR-10-0292","article-title":"DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer","volume":"16","author":"Alexander","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2011.05.033_bib21","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161102774X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161102774X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T07:24:40Z","timestamp":1543476280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161102774X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S036030161102774X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}